ABSTRACT: Increases in minute ventilation (V'E) have been observed during exacerbations of asthma and in response to administration of histamine. However, it is not yet clear how the breathing pattern is affected, and whether the increase in V'E is found in general.
Bronchoconstriction and hyperventilation occur dur ing exacerbations of asthma. Generally, arterial carbon dioxide tension (Pa,C0 2) does not change, or even decrea ses during exacerbations of asthma, indicating that ven tilation must have increased [1, 2] . It has been known for years that patients with asthma hyperventilate when acutely ill [3] [4] [5] . It has also been found that minute ventilation (V'E) increases in response to progressive methacholine-induced and histamine-induced broncho constriction [5] [6] [7] [8] [9] . Other studies, however, have indica ted that inhaled histamine or methacholine may result in a rapid, sometimes shallow, breathing pattern [10] , or that the breathing pattern is not changed in response to histamine or methacholine [11, 12] . Thus, results on ventilatory responses to induced bronchoconstriction reported in the literature are not consistent. S trom berg and G u sta fsso n [13] found that, during a histamine challenge, 4 out of 8 patients responded with an increase in V'E, whereas V'e was unchanged or tended to decre ase in the remaining patients. These authors suggested that the latter patients were "ventilatory nonresponders".
Recently, it has been shown, in a selected group of patients with asthma, that during histamine challenge tests changes in breathing pattern occur prior to changes in the forced expiratory volume in one second (FEVi) [14] . This finding suggests that the increase in airway resistance does not play the only role in the change in pattern of breathing, and, furthermore, that vagal air way receptors may be involved by direct stimulation. It is well-known that pulmonary receptors influence the breathing pattern [15, 16] . The duration of inspiration (tl) is controlled mainly by slowly-adapting stretch re ceptors (SARs) through the off-switch mechanism, and, at least in part, duration of expiration (fE) is determined by rapidly-adapting stretch receptors (RARs) [17] [18] [19] . In a previous study in cats, we found that respiratory freq uency (fR) increased significantly (p<0.01) in response to stimulation of RARs by intravenous administration of histamine [20] . During mechanical stimulation of RARs by continuous negative airway pressure, an incre ase in fR was also found [21] . RARs can be stimulated by histamine in two ways: mechanically (by broncho constriction) and chemically [22] [23] [24] [25] .
Functional residual capacity (FRC) may increase after N .E.L. MEESSEN ET AL administration of histamine. This is due to the concom itant broncho constriction and/or an increase in end-tidal inspiratory activity (ETIA) [26] . Changes in FRC may indirectly influence the breathing pattern because of the relationship between lung volume and the activity of pulmonary stretch receptors. Furthermore, an incre ase in FRC may limit the increase in Vr. It is not yet clear how the breathing pattern changes during exacerbations of asthma and induced bronchoconstriction. The aims of the present study, therefore, were: 1) to evaluate the effects of administration of his tamine on the breathing pattern and on FRC in humans; and 2) to evaluate whether the degree of bronchial respon siveness plays a role in histamine-induced changes in V'E.
M eth o d s

Subjects
Sixty three subjects participated in this study. Charac teristics of the subjects are presented in table 1. Bronchodilators were withheld for at least 8 h prior to the study. In a standardized histamine challenge test, the provocative concentration of histamine which caused a fall of >20% in FEVi (PC20) [27, 28] was determined. To shorten the duration of the test, the starting concen tration of histamine varied depending on the response to an aerosol of saline, and medication requirements [28] [29] [30] . A histamine concentration of 8 mg-ml/ 1 was used as the upper limit of the test. Forty four subjects show ed bronchial hyperresponsiveness (PC20 <8 mg-rnL'1) ("BHR+"). The remaining 19 subjects were not hyperresponsive (M BHR-,r). Informed consent was obtained from all subjects. The subjects were naive with respect to the scientific goals of the study. The study was appro ved by the hospital Medical Ethics Committee.
Experimental set-up
Aerosols were generated by a DeVilbiss 646 jet nebu lizer (Devilbiss Co., Somerset, PA, USA. The calibrated output of the nebulizer was 0.13 mL-min"1. The hista mine concentration that was used in the further experi- ments depended on the individual result of the histamine challenge protocol. In BHR+ subjects, ventilatory para meters were studied at the PC20 dose. In BHR-subjects, the ventilatory parameters were studied at a histamine dose of 8 mg-rnL"1.
FEVl and FVC were measured by a pneumotacho graph (Fukuda Sangyo, Tokyo, Japan). Changes (A) in FRC, fR tidal volume (Vt) and V'E were calculated from the spirograms recorded before and after inhalation of histamine. Two methods were applied to record these spirograms: 1) using a wedge spirometer in a closed brea thing circuit; and 2) using respiratory inductive plethys mography (RIP) (Respitrace®; Respitrace Ca, Ardsley, USA). Values were related to the reference values of the European Respiratory Society [31] .
Forty one subjects (29 BHR+ and 12 BHR-) were connected to the closed breathing circuit by a mouth piece. A blower maintained a constant bias flow in the circuit (120 L-min*1). Gas was sampled continuously from the circuit for measurement of the oxygen concentra tion (Taylor Servomex, Sussex, UK), and subsequently fed back into the system ( fig. 1 ). Oxygen was supplied to maintain a constant oxygen concentration (21%) in the circuit. Exhaled C 0 2 was absorbed by soda lime. A mismatch between 0 2 supply and 0 2 uptake by the sub ject would cause the baseline of the spirometer signal to drift one way or the other, which would affect the result for AFRC. The shift of the baseline of the spiro meter signal (AV) is proportional to the deviation of the 0 2 concentration (ACo2) from 21%. The relationship between AV and ACo2 was determined experimentally by adding a known amount of pure oxygen to the sys tem and reading the corresponding change in Co2. With the help of this relationship, we have corrected the raw data for AFRC for the aforementioned Correlated shift of the baseline of the spirometer signal. The inaccura cy of the correction was ±6 mL. This error adds to the overall random error in the determination of AFRC. The DeVilbiss 646 jet nebulizer was connected to the cir cuit near the mouthpiece ( fig. 1 ).
The remaining subjects (15 BHR+ and 7 BHR-) were connected to the RIP system and via a mouthpiece to the nebulizer. The RIP was used in the direct current (DC)-mode. Volume calibration of the Respitrace was performed with a spirometer (Hospal, Littleton, CO, USA), just prior to the administration of the aerosol of histamine, and immediately after the recording had been ended while the subject was still sitting in the same position. If the two calibration factors differed by more than 10%, the measurement was excluded from the study. Thus, for each subject, a conversion factor was cal culated from the lung volume changes measured with the spirometer and the associated deflections obtained from the RIP.
The spirograms were recorded with a multichannel X-t recorder (Kip, The Netherlands) for off-line analy sis of the changes in V'e, VT, fR and FRC. All subjects were tested in the sitting position, whilst breathing thro ugh the mouthpiece with the nose clipped. When the subjects were seated in a relaxed posture, they were asked to remain seated in that way until the end of the recording. Thus, with the co-operation of the subjects, we were able to minimize the impact of postural mus cles on the volume changes recorded. To divert their attention from breathing, the subjects were asked to con centrate on a poster placed in front of them. 
Experimental protocol
Recording was started after the subjects had been con nected to the mouthpiece. The uninterrupted recording included control breaths, breaths during the period of 2 min of inhalation of histamine, and for at least 1 min following inhalation of histamine. FEVi and FVC were measured immediately before this recording, and 1.5 min after inhalation of histamine had been stopped.
Statistical analysis
From each recording, two sets of values for ƒ&, VT, and V'e were calculated from five consecutive control breaths just prior to the inhalation of histamine, and from five consecutive breaths 1 min after inhalation of histamine, respectively. The AFRC was calculated from the shift in the baseline of the spirometer signal between these two groups of breaths.
Differences between the results before (control) and after inhalation of histamine, and differences between the results of the two groups (BHR+ and BHR-) were evaluated for statistical significance using the t-test for paired observations and the t-test for unpaired observa tions, respectively. A p-value of less than 0.05 was con sidered to be significant.
R esults
The characteristics of the subjects are presented in table 1. Sex, age and height were not significantly dif ferent between BHR+ and BHR-. For BHR+, BHR-and the group as a whole, FEVl decreased significantly in response to the dose of histamine applied as compared with control values. The mean concentration of hista mine administered to BHR+ (3.5 m g-m l/1) was less than half of that administered to BHR-(8.0 m g-m l/1)-Nonetheless, the decrease in FEVl in BHR+ was con siderably larger than that in BHR-. Ventilatory responses to inhalation of histamine deter mined with the spirometer and by RIP were qualitati vely and quantitatively the same» and, as a consequence, the data were pooled. Table 2 presents the results, V'E increased significantly in BHR-as compared with con trol values before inhalation of histamine. The changes in V'E were not significant in BHR+. Breathing fre quency increased significantly in the whole group, BHR+ and BHR-. Although, on average, the control values of fR were higher in BHR+, a further significant increase in fR was found in response to histamine. In the whole group, BHR+ and BHR-, no significant changes were found in Vr between control and histamine values. Both control values of Vr and Vr after histamine were sig nificantly higher in BHR-as compared to BHR-k Mean± sem increase in FRC after inhalation of histamine was 0,26±0.03 L, which was 8±1% of predicted. This incre ase in FRC was significantly (pcO.Ol) larger in BHR+ than in BHR-. Figure 2a and b shows the relationships between AV'E and AFEV l in response to histamine and between À V'E and the histamine concentration applied, respec tively. Results are presented separately for BHR+ and BHR-. A significant correlation was found for the rela tionship between A V e and AFEVl for BHR+ (n=-0.319; p<0.05) and for the whole group (r=-0.273; p<0.05), but not for BHR-. Thus, it appeared that the subjects with the largest decrease in V'E showed a relatively large de crease in FEVl. No significant relationship was found between À V'E and the histamine concentration applied.
Discussion
The changes in V'E, fR and Vr were not uniform; com parable numbers of subjects responded with increases (n=33) and decreases (n=30) in V'E. F o r/ r , 40 subjects responded with an increase and 23 with a decrease; and for Vr, these numbers were 26 and 37, respectively. These results are in agreement with the observations of S trom berg and G u s t a f s so n [13] , who found that 50% of their subjects responded to histamine with an incre ase in V'E whereas, in the other 50% V'E was unchanged or tended to decrease.
The use of a mouthpiece and noseclip may be criti cized. Effects of a mouthpiece on breathing pattern have been described in the literature but conclusions are not consistent [3] , In the present study, we have evaluated the effects of inhalation of histamine on respiratory vari ables. Values after histamine were compared to control values; Le. before the start of histamine nebulization. Thus, baseline values were obtained after subjects had been connected to the mouthpiece and the nose had been clipped. Hence, the differences in breathing pat tern found in response to histamine cannot be attributed to an effect of the mouthpiece or noseclip. It has recent ly been reported that ventilatory responses (Le. V'E) to inhaled histamine, measured by RIP, were diminished when breathing through a mouthpiece whilst wearing a noseclip [13] . All of our subjects breathed through a mouthpiece with the nose clipped. This might explain why we found a considerable number of ventilatory nonresponders. If changes in breathing pattern induced by inhalation of histamine are masked by an effect of the mouthpiece and noseclip, responses in our study may be underestimated.
Histamine may stimulate RARs in two ways: mechan ically (by histamine-induced bronchoconstriction) and chemically. In our previous studies in cats [20, 21] , we observed that stimulation of RARs either by negative airway pressure or by administration of histamine led to an increase in fR. We think, therefore, that histamineinduced increases in fR seen in the present study (table  2) were due, at least in part, to a vagal reflex in which RARs are involved.
In the subjects who were BHR+, the response of FRC on histamine was larger than in normal subjects (table  2) . This can be attributed to the more pronounced air flow limitation and the possible presence of end-tidal inspiratory activity during increased activity of RARs [20, 21] . An increase in FRC may limit an increase in Vr or even cause a decrease in Vr with a concomitant decrease in V'E. Moreover, the increased airway resist ance after inhalation of histamine may cause a decrease in Vr and V'E in subjects with large decreases in FEVl. This may explain: 1) why we found that V'E was neg atively correlated to AFEVl ( fig. 2) , Le. V'E decreased especially in subjects with large decreases in FEVl (BHR+); and 2) why the increase in V'E after histamine was not significant in subjects who were hyperresponsive (table 2), A combination of histamine-induced increases in / R and bronchoconstriction-induced reduc tions in Vr may explain why, in several subjects (n=24), opposite responses were seen, Le. fR increased whilst simultaneously Vr decreased.
We conclude that, in general, respiratory responses to inhaled histamine are not predictable. Respiratory fre quency increased significantly both in hyperresponsive and nonhyperresponsive subjects. The concomitant in crease in minute ventilation, however, was significant in nonhyperresponsive subjects but not in hyperrespon sive subjects. These findings may be interpreted to indi cate that different mechanisms with opposite effects may be operating simultaneously, e.g. excitation of cen tral inspiratory activity by stimulation of rapidly-adapting pulmonary stretch receptors, which will promote increases in respiratory frequency, tidal volume and minute ventilation, and bronchoconstriction with increa sed airway resistance, which will promote decreases in these parameters. As a consequence, depending on the net result of these opposite contributions to, for instance minute ventilation, administration of histamine will cause an increase in minute ventilation in one subject and a decrease in another subject.
